Exchange: NASDAQ·Updated 04:32 PM EDT
ENGN logo

ENGN enGene Holdings Inc

$1.84
$0.015
(0.82%)
Today
Closed $1.84
$0.00
(0.00%)
After Hours
EarningsSep 14
Mkt Cap$122.26M
Vol291,271.00

About ENGN

enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
43

Bearish Sentiment

How do you feel about ENGN?

Advertisement|Remove ads.